# Odevixibat Pregnancy and Lactation Surveillance Program: A Study to Evaluate the Safety of Odevixibat During Pregnancy and/or Lactation

> **NCT06258902** · — · RECRUITING · sponsor: **Ipsen** · enrollment: 20 (estimated)

## Conditions studied

- Pregnancy Related

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06258902
- **Lead sponsor:** Ipsen
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-09-28
- **Primary completion:** 2032-05-31
- **Final completion:** 2032-05-31
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06258902

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06258902, "Odevixibat Pregnancy and Lactation Surveillance Program: A Study to Evaluate the Safety of Odevixibat During Pregnancy and/or Lactation". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT06258902. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*